Abstract

The originally published version of this Article contained an error in the spelling of the author Nathaniel W. Oswald, which was incorrectly given as Nathaniel W. Olswald. This has now been corrected in both the PDF and HTML versions of the Article.

Details

Title
Author Correction: Small-molecule TFEB pathway agonists that ameliorate metabolic syndrome in mice and extend C. elegans lifespan
Author
Wang, Chensu 1 ; Niederstrasser, Hanspeter 2 ; Douglas, Peter M 3 ; Lin, Rueyling 3 ; Jaramillo, Juan 3 ; Yang, Li 4 ; Oswald, Nathaniel W 2 ; Zhou, Anwu 2 ; McMillan, Elizabeth A 5 ; Mendiratta, Saurabh 5 ; Wang, Zhaohui 4 ; Zhao, Tian 4 ; Lin, Zhiqaing 4 ; Luo, Min 4 ; Huang, Gang 4 ; Brekken, Rolf A 6 ; Posner, Bruce A 2 ; MacMillan, John B 2 ; Gao, Jinming 4 ; White, Michael A 5 

 Department of Pharmacology, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA; Department of Cell Biology, University of Texas Southwestern Medical Center, Dallas, TX, USA 
 Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas, TX, USA 
 Department of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, TX, USA 
 Department of Pharmacology, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA 
 Department of Cell Biology, University of Texas Southwestern Medical Center, Dallas, TX, USA 
 Department of Pharmacology, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA; Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX, USA 
Pages
1-1
Publication year
2018
Publication date
May 2018
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2042223523
Copyright
© 2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.